Abstract
Data on the psychopharmacological treatment of 3792 inpatients with mono- or bipolar depression during a twelve-year period were routinely documented in a systematic way by means of an electronic data processing system. Thirty-three of these patients committed suicide while in hospital; the remaining patients were used as controls (n = 3759). To identify possible differences in the pharmacological treatment of suicides and controls the data were classified according to the following drugs and drug groups: antidepressants, neuroleptics, tranquilizers, hypnotics, lithium, biperiden, beta-adrenergic blocking drugs, placebos and others. A comparison was made of how frequently the drugs were prescribed and of the mean number of prescriptions of neuroleptics, tranquilizers and antidepressants; the latter were in addition differentiated in sedating and non-sedating drugs. Moreover the mean daily dose of frequently used substances was compared. Whereas no significant difference for the groups was found with respect to the percentage of patients undergoing neuroleptic treatment, the mean number of prescriptions of neuroleptics was significantly higher at 1.3 per patient for the suicides than for the controls at 0.8 per patient. Furthermore a tendency towards a lower frequency of the prescription of lithium together with a lower mean dosage emerged for the suicides. No other hints of differences in the psychopharmacological treatment of suicides were found.
This is a preview of subscription content, log in via an institution to check access.
References
Ahrens, B., Grof, P., Moller, H. J., Muller-Oerlinghausen, B. & Wolf, T. (1995). Extended survival of patients on long-term lithium treatment. Canadian Journal of Psychiatry, 40(5), 241-6.
Cohen, S., Leonard, C. V., Farberow, N. L. & Shneidman, E. S. (1964). Tranquilizers and suicide in the schizophrenic patient. Archives of General Psychiatry, 11 312-321.
Coppen, A. (1994). Depression as a lethal disease: Prevention strategies. Journal of Clinical Psychiatry, 55(4,suppl), 37-45.
Finzen, A. (1988). Der Patientensuizid:Untersuchungen, Analysen, Berichte zur Selbsttötung psychisch Kranker während der Behandlung. Bonn: PsychiatrieVerlag.
Galdi, J. & Hirsch, S. R. (1983). The causality of depression in schizophrenia. British Journal of Psychiatry, 142 621-625.
Glen, A., Dodd, M., Hulme, N. & Kreitman, N. (1979). Mortality on lithium. Neuropsychobiology, 5 167-169.
Goldney, R. D., Positano, S., Spence, N. & Rosenman, S. (1985). Suicide in association with psychiatric hospitalisation. Australian and New Zealand Journal of Psychiatry, 19 177-183.
Grohmann, R., Rüther, E. & Schmidt, L. G. (Eds.). (1994). Unerwünschte Wirkungen von Psychopharmaka. Ergebnissse der AM ÜPStudie. Berlin Heidelberg: Springer.
Guy, W. & Ban, T. A. (Eds.). (1982). The AMDP-System. Manual for the assessment and documentation of psychopathology. Berlin Heidelberg, New York: Springer.
Guze, S. & Robins, E. (1970). Suicide and primary affective disorder. British Journal of Psychiatry, 117 437-438.
Helmchen, H. (1985). The AMDP. In P. Pichot (Ed.), Psychiatry. The state of the art. Vol. 1. Clinical Psychopathology, nomenclature and classification(pp. 141-146). New York: Plenum Press.
Hessö, R. (1977). Suicide in Norwegian, Finnish, and Swedish psychiatric hospitals. Archiv für Psychiatrie und Nervenkrankheiten, 224(2), 119-27.
Hussar, A. E. (1962). Effect of tranquilizers on medical morbidity and mortality in a mental hospital. Journal of the American Medical Association, 179 682-686.
Kapur, S., Mieczkowski, T. & Mann, J. J. (1992). Antidepressant medications and the relative risk of suicide attempt and suicide. Journal of the American Medical Association, 268(24), 3441-5.
Lepkifker, E., Horesh, N. & Floru, S. (1985). Long-term lithium prophylaxis in recurrent unipolar depression. Acta psychiatrica Belgica, 85 434-443.
Litovitz, T., Bailey, K., Schmitz, B., Holm, K. & Klien-Schwarz, W. (1991). 1990 annual Report of the American Association of Poison Control Centers National Data Collection System. American Journal of Emergency Medicine, 9 461-509.
Menninger, K. (1938). Man against Himself. London: Harrap.
Modestin, J. (1985). Antidepressive therapy in depressed clinical suicides. Acta psychiatrica Scandinavica, 71 111-116.
Modestin, J. & Schwarzenbach, J. (1992). Effect of psychopharmacotherapy on suicide risk in discharged psychiatric inpatients. Acta psychiatrica Scandinavica, 85 173-175.
Möller, H.J. (1992). Antidepressants - Do they decrease or increase suicidality. Pharmacopsychiatry, 25 249-253.
Möller, H.J. (1995). Suizidalität unter Antidepressivabehandlung. In M. Wolfersdorf & W. P. Kaschka (Eds.), Suizidalität - Die biologische Dimension. Berlin Heidelberg: Springer.
Möller, H.J.& Zerssen, D. v. (1981). Depressive Symptomatik imstationären Behandlungsverlauf von 280 schizophrenen Patienten. Pharmakopsychiatrie, 14 172-179.
Muller-Oerlinghausen, B., Ahrens, B., Grof, E., Grof, P., Lenz, G., Schou, M., Simhandl, C., Thau, K., Volk, J., Wolf, R. & et al. (1992a). The effect of long-term lithium treatment on the mortality of patients with manic-depressive and schizoaffective illness. Acta psychiatrica Scandinavica, 86(3), 218-22.
Muller-Oerlinghausen, B., Muser-Causemann, B. & Volk, J. (1992b). Suicides and parasuicides in a hig-hrisk patient group on and off lithium long-term medication. Journal of Affective Disorders, 25(4), 261-9.
Myers, D. & Neal, C. (1978). Suicide in psychiatric patients. British Journal of Psychiatry, 133 38-44.
Nilsson, A. (1995). Mortality in recurrent mood disorders during periods on and off lithium. A complete population study in 362 patients. Pharmacopsychiatry, 28(1), 8-13.
Norton, B. & Whalley, L. (1984). Mortality of a lithium treated population. British Journal of Psychiatry, 145 277-282.
Pokorny, A. (1983). Prediction of suicide in psychiatric patients. Archives of General Psychiatry, 40 249-257.
Price, L. H., Charney, D. S., Delgado, P. M. & Heninger, G. R. (1990). Lithium and serotonin function: implications for the serotonin hypothesis of depression. Psychopharmacology, 100 3-12.
Rouillon, F., Philipps, R. & Serrurier, D. (1989). Recurrence of unipolar depression efficacy of maprotiline. Encéphale, 15 527-534.
Roy, A. (1982). Risk factors for suicide in psychiatric patients. Archives of General Psychiatry, 39(9), 1089-95.
Roy, A. (1985). Suicide. A multidetermined act. Psychiatric Clinic of North America, 8(2), 243-50.
Taiminen, J. & Kujari, H. (1994). Antipsychotic medication and suicide risk among schizophrenic and paranoid inpatients. Acta psychiatrica Scandinavica, 90 247-251.
Thies-Flechtner, K., Müller-Oerlinghausen, B., Seibert, W., Walther, A. & Greil, W. (1996). Effect of prophylactic treatment on suicide risk in patients with major affective disorders. Pharmacopsychiatry, 29 103-107.
Vestergaard, P. & Aagaard, J. (1991). Five-year mortality in lithium-treated manic-depressive patients. Journal of Affective Disorders, 21 33-38.
Wickham, E. A. & Reed, J. V. (1987). Lithium for the control of aggressive and self-mutilating behaviour. International Clinical Psychopharmacology, 2 181-190.
Wolfersdorf, M. (1989). Suizid bei stationären psychiatrischen Patienten. Regensburg: Roderer.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Krupinski, M., Fischer, A., Grohmann, R. et al. Psychopharmacological therapy and suicide of inpatients with depressive psychoses. Archives of Suicide Research 4, 143–155 (1998). https://doi.org/10.1023/A:1009615914868
Issue Date:
DOI: https://doi.org/10.1023/A:1009615914868